The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Rapidly alternating chemotherapy and radiotherapy in advanced laryngeal cancers.
Yasuhisa Hasegawa
No relevant relationships to disclose
Yasushi Fujimoto
No relevant relationships to disclose
Kunitoshi Yoshino
No relevant relationships to disclose
Nobuhiro Hanai
No relevant relationships to disclose
Taijirou Ozawa
No relevant relationships to disclose
Hitoshi Hirakawa
No relevant relationships to disclose
Hidenori Suzuki
No relevant relationships to disclose
Kei Ijichi
No relevant relationships to disclose